retroviral sf71-gp91phox transduced cd34+ cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00564759)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- retroviral sf71-gp91phox transduced cd34+ cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00927134 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2004 | J. W. Goethe University, University of Zurich |
| NCT00564759 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2004 | German Federal Ministry of Education and Research, J. W. Goethe University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| J. W. Goethe University | Academic/Hospital | 2 | 1 | 1 | 2004 |
| German Federal Ministry of Education and Research | Government | 1 | 0 | 1 | 2004 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2004 |
3 organizations
Page 1 / 1